Preview

Pharmaceutical Industry and Drug

Good Essays
Open Document
Open Document
2388 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pharmaceutical Industry and Drug
Chapter 21

Questions 1 through 7

1. On balance, do you think Merck is an ethical and socially responsible company? Why or why not? How about Pfizer?

In my opinion, Merck is not an ethical and socially responsible company with introducing Vioxx into pharmaceutical market. Before the Vioxx approval by FDA, scientists from University of Pennsylvania found that the drug could bring some serious results such as cardiovascular, and there were many serious cardiovascular problems during testing on patients. However, Merck ignored these negative effects, kept developing Vioxx was order to get ample profits. At the same time , through “Direct-to-consumer advertising”, Merck made customers believe Vioxx that was safer and more effective than other same products. So, I do not think Merck is an ethical and socially responsible company.
Pfizer is not an ethical and socially responsible company. Pfizer refused to take Celebrex off the market when Vioxx had been recalled, even Celebrex had same problems with Vioxx. Prizer wanted to take this chance from big trouble in Vioxx to occupy more market share despite Celebrex can be result in health-attack risks.

2. How could the disaster with Vioxx have been avoided in the first place?
First of all, in my opinion, Merck should listen carefully to suggestions from scientists who are from university of Pennsylvania, which is that Vioxx would lead to heart attacks and strokes. At that time, Merck should be aware of risk of health for people, and redevelop Vioxx. Moreover, as local government, they should control and monitor pharmaceutical advertising, avoid customers being tricked through fake data from this kind of pharmaceutical advertising.

3. What is your opinion of pharmaceutical advertising?
Firstly, this kind of pharmaceutical advertising in terms of direct-to-customer can improve patient awareness to drugs. For instance, a person with disease does not know that there are some drugs that can cover and

You May Also Find These Documents Helpful

  • Good Essays

    Merck and Vioxx

    • 972 Words
    • 4 Pages

    In May of 1999, the FDA approved the use of rofecoxib. Marketed under the name of Vioxx, rofecoxib was manufactured and distributed by Merck, a large pharmaceutical company. Doctors prescribed the drug as a non-steroidal anti-inflammatory and prescription painkiller. Five years after its release, rofecoxib was withdrawn because of a study that showed the drug more than doubled the risk of heart attack or stroke. Because of Merck’s ongoing and increasing knowledge of the dangerous effects of the drug while continuing to distribute rofecoxib, Merck should be held accountable for acting unethically.…

    • 972 Words
    • 4 Pages
    Good Essays
  • Good Essays

    The actions Merck undertook when marketing Vioxx and emphasizing its safety even after finding out the product’s side effects endangered all its key stakeholders and showed the real face of the company that accented its highly ethical maxims. Cardiovascular side effects of the Vioxx increased the risk of complications that could have caused patient’s death, therefore Merck violated the basic right to life of all the Vioxx consumers. It was already mentioned that Vioxx caused 3468 deaths by heart attack and stroke. All these tragedy events could have been prevented if Merck provided adequate information about all the peculiarities of Vioxx. Even though Merck argued that the withdrawal of tests results was caused by its utilitarian intention…

    • 578 Words
    • 3 Pages
    Good Essays
  • Good Essays

    However, several studies have questioned the cardiovascular safety of Vioxx. The manufacture of Vioxx has announced a voluntary withdrawal of the drug from the U.S. and worldwide market in September 30, 2004. After the company’s own 3 year study was stopped. Two million Americans were taking Vioxx when it was pulled and Merck had said that approximately 20 million people in the U.S. have used the drug. This withdrawal was due to some safety concerns of an increased risk of cardiovascular events, including heart attacks and strokes in patients taking Vioxx during the first 18 months. In the 5 years that Vioxx was on the market over 88,000 and 140,000 cases of heart disease were reported, of those cases 30 to 40 percent were fatal. The records indicate that the action of both Merck and the US Food and Drug Administration (FDA) found nearly 30,000 excess cases of heart attacks and sudden cardiac deaths that resulted from the use of this drug between 1999 and 2003. Over 300 lawsuits have been filed against Merck, and was expected that thousand more will…

    • 830 Words
    • 4 Pages
    Good Essays
  • Good Essays

    The ethical dilemma that arises from this is the people that need the drug may or may not be able to afford the medication they need to survive. Pharmaceutical companies began trying to work with the manufactures and offer the medicine to those that did not have the means at a discounted price however they were not reduced enough for many that needed the drug to live.…

    • 731 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Res 351 week 2

    • 985 Words
    • 3 Pages

    Merck & Co. marketed a drug called Vioxx. The drug was said to have less gastrointestinal problems than its competition – Naproxen. However, Vioxx had considerably more side effects including; heart attacks and strokes (Vershoor,C.C, 2006). Merck and Co. were accused of several unethical acts, therefore, the drugs were pulled from the market in September 2004. Unfortunately, not before 100 million prescriptions were filled. Merck & Co. was also accused of misrepresenting or concealing of study results to doctors. The New England Journal of Medicine reported that previous studies of three patients had been withheld. All three patients suffered heart attacks when taking Vioxx. Sales reps for Merck & Co. were trained to use subliminal selling tactics. Additionally, Merck & Co. only chose biased speakers of their products at educational…

    • 985 Words
    • 3 Pages
    Better Essays
  • Satisfactory Essays

    The manufacturer also overdid the promotion on the drug therefore endangering millions of lives through the huge sales made.…

    • 528 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Brain Gym Analysis

    • 1243 Words
    • 5 Pages

    Drug companies distribute and promote their changed results in academic journals, tricking very nearly anybody into putting their dangerous and inaccurately tested drugs on the market. In duplicate publication if a drug company gets a better result, they will republish their findings in slightly different ways and in multiple academic sources. “One drug called ondansetron managed to overestimate the drug's effect by 23% using this method” (Goldacre, 2011, pp.164-165). Side effects usually happen and can often be severe. Harmful side effects and their negative results, when known, can discourage medicine buyers. Drug companies can muffle the negative reactions by contrasting them with horrible symptoms that another, comparative medication may have. According to drugwatch.com, one type 2 diabetes drug, Actos, which was prescribed 10 million times and FDA approved, increases the chance of bladder cancer by 40% and causes an increased risk of heart failure. Vioxx a painkiller that was approved in 1999 by the FDA was studied in a trial against an older drug, naproxen, to compare the different side effects much money was invested in the trial, and the pending…

    • 1243 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Analysis of the Medicines Company case revealed several critical aspects that need to be addressed. The pharmaceutical industry can be very profitable, but is also very risky. As described in the case, bringing a new drug to market is a costly and lengthy process requiring an average of 10 years. Big Pharmaceutical companies struggle to keep upcoming drugs in their pipeline to provide revenue when existing drugs come off patent and are replaced by generic compounds. With 1 in 4000 compounds making it to market, there is significant risk of failure that can be reduced by having many compounds in development. Additionally, a drug company's reputation can easily be tarnished by safety issues with a compound, dramatically affecting their sales.…

    • 2114 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    Merck Business Analysis

    • 1943 Words
    • 8 Pages

    Scheller, A. (April 2011). Merck chairman discusses corporate responsibility at speaker series. Kogod News. Retrieved from http://www.american.edu/kogod/news/20110324_ksb_richard_clark.cfm…

    • 1943 Words
    • 8 Pages
    Powerful Essays
  • Better Essays

    Merck and Vioxx Analysis

    • 1612 Words
    • 7 Pages

    2) Was Merck really acting in pursuit of their own self interests in aim of excessive profits and majority market share despite the risks?…

    • 1612 Words
    • 7 Pages
    Better Essays
  • Good Essays

    Merck Essay

    • 695 Words
    • 3 Pages

    The decision to move forward with the program to donate the new drug Mectizan on a large scale to the affected population in the Third World needs to be systematically analyzed. There are two especially important angles from which this decision needs to be considered. The first concern that needs to be taken into account is that of the stockholders and investors in this company, whose interests you are ultimately charged with representing. The second concern deals with the extent and limits of Merck's social responsibilities. These two issues are not necessarily incongruent with each other. As an advisor to this Office, I recommend Merck to proceed with the program to donate Mectizan on a large scale to the affected population. My arguments that support this decision are outlined in the following paragraphs, and are based on precepts and writings on corporate social responsibility and ethics.…

    • 695 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    What Did Merck Do

    • 464 Words
    • 2 Pages

    Merck is a pharmaceutical company that we often see on television for their prescription drug ads. They were known for their ability to produce 13 new drugs from 1995 to 2001, of which included the painkiller Vioxx. The drug was supposed to beat out Pfizer’s, Celebrex, and Bextra because it was gentler on the stomach. (www.cbsnews.com) But was that the only thing different Vioxx could do?…

    • 464 Words
    • 2 Pages
    Satisfactory Essays
  • Best Essays

    The current model of the pharmaceutical market creates a conflict between the competing interests of the patients and the pharmaceutical industry where the increasing market expansion and profitability of the industry is happening at the cost of patients’ ability to receive the most appropriate and effective treatment. The interests of the Pharmaceutical industry outcompeted the interests of patients and public health providers by the increased integration and resulting influence of the pharmaceutical industry in all aspects of healthcare and medical research. This increased influence of the pharmaceutical companies allowed them to expand rapidly through mainly two complementary processes: Disease-mongering and “pharmaceuticalisation”. Disease-mongering is described as efforts to enlarge the market of a treatment by either narrowing the definition of health so more people seek medical intervention or by broadening the definition of disease so milder symptoms and health conditions now require medical intervention. Pharmaceuticalisation is the increasing belief of individuals and healthcare providers that the best method of treating most ailments is only through a pharmaceutical solution. (Applbaum 84-102) These two processes have led to an environment where the prescription of a specific treatment does not depend on how effective it is but rather how well the manufacturer of the treatment has marketed their brand in comparison to other treatments. The total spending on pharmaceuticals across OECD countries is estimated to be more than 700 billion USD in 2009. (OECD 7.4) This incredible amount of revenue and wealth gives the pharmaceutical industry an equally vast amount of power and ability to influence.…

    • 4286 Words
    • 18 Pages
    Best Essays
  • Good Essays

    Merck Vioxx Recall

    • 1169 Words
    • 5 Pages

    In 2005, Merck was ranked fourth in sales among pharmaceutical companies. Merck had released the drug Vioxx, for treating Osteoarthritis in late 1990. Merck as a company has a reputation of being one of the most ethical and socially responsible drug company established. The company’s Philanthropy was “Legendary” (Lawrence & Weber, 2011). A quote from George Merck, CEO, stated “We try never to forget the medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they will never fail to appear,” this shows the efforts made by the company in adhering to its core values (pg. 481, Lawrence & Weber, 2011). Merck acted in a responsible manner because of the voluntary worldwide withdrawal of the drug Vioxx. The decision Merck took, was to withdraw Vioxx from the market which was based on some new data from the clinical trial called the APPROVe (Adenomatous Polyp Prevention on Vioxx).…

    • 1169 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Merck and River Blindness

    • 1810 Words
    • 8 Pages

    From a rights/responsibility lens it would appear that Merck has chosen to honor the principles outlined by their founder by adhering to the mission statement. The results lens allows…

    • 1810 Words
    • 8 Pages
    Powerful Essays